Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Intellipharmaceutics International Inc
V.IPCI.H
Alternate Symbol(s):
IPCIQ
Healthcare
Biotechnology
Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several...
drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:IPCI.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
Next
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 18, 2020 1:26am
RE:RE:RE:Did you notice?
if FDA every time does what AdCom decides why do we need FDA at all, let AdCom issue all the drug permits, we'll save millions on all those FDA salaries, ha
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 17, 2020 6:46pm
RE:RE:RE:Did you notice?
the FDA may feel guilty that it told Odidi to do more checking on the oral and nasal aspects of Aximiris which he did and then it rejected it anyway. Can somebody say "lawsuit"?
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 17, 2020 3:04pm
RE:RE:Did you notice?
this dummy Odidi put all his money on the Oxy Aximiris and totally neglected Regabatin. He thought that if he monkeys around with Aximiris a little bit he'll be able to fool FDA to grant the
...more
(4)
•••
FredZarfloon
X
View Profile
View Bullboard History
Comment by
FredZarfloon
on Jan 17, 2020 12:08pm
RE:Did you notice?
In 2015 "FDA completed its review of the (Regabatin) IND application and provided constructive input that we will use towards further development of the program." Looks like it ain't
...more
(2)
•••
Nogah3
X
View Profile
View Bullboard History
Post by
Nogah3
on Jan 16, 2020 10:15pm
Did you notice?
Hi all, I spoke about this company's advancement (licensing out 3 drugs) for Q4 and its even greater potential which unfortunately the market does not understand. The final point I wished to
...more
(0)
•••
xymptlx
X
View Profile
View Bullboard History
Comment by
xymptlx
on Jan 16, 2020 3:58pm
RE:RE:RE:Pipeline
What are they waiting for then? I don't think these guys can market anything by the looks of it.
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 16, 2020 3:08pm
RE:Nice insider scam here, will be some jail time for someone.
it's interestng that there is no date for the FDA decision, it may come tomorrow or it may never come, ha
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 16, 2020 1:16pm
RE:RE:IntelliPharmaCeutics Aximris drug gets rejected by FDA
maybe they could sell it so some 3rd World countries, even if it prevents opium abuse a little bit ist's still better than nothing
(25)
•••
mingzhu
X
View Profile
View Bullboard History
Comment by
mingzhu
on Jan 16, 2020 1:07pm
RE:IntelliPharmaCeutics Aximris drug gets rejected by FDA
IntelliPharmaCeutics Aximris drug gets rejected by FDA 2020-01-16 09:56 ET - News Release Mr. Greg Powell reports INTELLIPHARMACEUTICS PROVIDES UPDATE ON FDA ADVISORY
...more
(25)
•••
mingzhu
X
View Profile
View Bullboard History
Post by
mingzhu
on Jan 16, 2020 1:04pm
IntelliPharmaCeutics Aximris drug gets rejected by FDA
eom
(1)
•••
OK_trade
X
View Profile
View Bullboard History
Comment by
OK_trade
on Jan 16, 2020 12:16pm
RE:News?
This is not right! The company halts the trading yesterday due to pending news. The company resumes trading this morning without the news release. The only "info" I got is from the SH
...more
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 16, 2020 11:34am
RE:RE:RE:RE:Anyone selling this morning...
it shows how dangerous is to apply to FDA for the second time after being rejected the first time - the same happened to another Canadian company recently, CORV, who also thought they did all the
...more
(38)
•••
driller1a
X
View Profile
View Bullboard History
Comment by
driller1a
on Jan 16, 2020 9:53am
RE:RE:RE:Anyone selling this morning...
...and if the company issues any news remotely positive .50-.60 cents without breaking a sweat.
(38)
•••
driller1a
X
View Profile
View Bullboard History
Comment by
driller1a
on Jan 16, 2020 9:51am
RE:RE:Anyone selling this morning...
.19 cents Smart move this will close between .30-.40 Unless the company has issued an official news release stating they are out of business then this drop is unwarranted and panic based
...more
(1)
•••
OK_trade
X
View Profile
View Bullboard History
Post by
OK_trade
on Jan 16, 2020 9:49am
News?
Have they announced any news? I don't see here at SH.
Prev
1
2
3
4
5
6
7
8
9
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.